You are here: Home » PTI Stories » National » News
Business Standard

USFDA completes inspection of Lupin's Nagpur plant

Press Trust of India  |  New Delhi 

Pharma today said the US health regulator has completed inspection of its facility without making any observations.

In a BSE filing, "announced successful completion of an inspection carried out by the Food and Drug Administration (USFDA) at its facility. The inspection concluded without any observations".

said its facility manufactures

Shares of Lupin were trading 2.09 per cent higher at Rs 767.50 on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, May 14 2018. 10:30 IST